Next Article in Journal
Aberrant GLI1 Activation in DNA Damage Response, Carcinogenesis and Chemoresistance
Previous Article in Journal
Diet and Pancreatic Cancer Prevention
Previous Article in Special Issue
Insights into the Molecular Pathogenesis of Activated B-Cell-like Diffuse Large B-Cell Lymphoma and Its Therapeutic Implications
Article Menu

Export Article

Open AccessReview
Cancers 2015, 7(4), 2318-2329; doi:10.3390/cancers7040893

Optimizing Management of Patients with Adult T Cell Leukemia-Lymphoma

Marlene and Stewart Greenebaum Cancer Center, University of Maryland School of Medicine, 22 S. Greene Street, Baltimore, MD 21204, USA
These authors contributed equally to this work.
*
Author to whom correspondence should be addressed.
Academic Editor: Jonas Cicenas
Received: 17 September 2015 / Revised: 5 November 2015 / Accepted: 17 November 2015 / Published: 25 November 2015
(This article belongs to the Special Issue Lymphoma)
View Full-Text   |   Download PDF [617 KB, uploaded 25 November 2015]   |  

Abstract

Adult T cell leukemia-lymphoma is a rare disease with a high mortality rate, and is challenging for the clinician. Early allogeneic stem cell transplant can confer durable remission. As novel therapeutic agents become available to treat T cell malignancies, it is increasingly important that medical oncologists, hematologists, and hematopathologists recognize and accurately diagnose adult T cell leukemia-lymphoma. There is no uniform standard of treatment of adult T cell leukemia-lymphoma, and clinical trials remain critical to improving outcomes. Here we present one management approach based on the recent advances in treatment for adult T cell leukemia-lymphoma patients. View Full-Text
Keywords: adult T cell leukemia-lymphoma; ATL; ATLL; allogeneic; HTLV-1; transplantation; chemotherapy; antiviral treatment adult T cell leukemia-lymphoma; ATL; ATLL; allogeneic; HTLV-1; transplantation; chemotherapy; antiviral treatment
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Yared, J.A.; Kimball, A.S. Optimizing Management of Patients with Adult T Cell Leukemia-Lymphoma. Cancers 2015, 7, 2318-2329.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top